HIV prevention drug hailed as breakthrough, but who gets access?

Lenacapavir, a twice-a-year injection could transform HIV prevention, but it will not be available to all.

Published on RocksNews: 1 Oct 2026, 14:13 UTC
Updated: 1 Oct 2026, 14:13 UTC
Language: English

HIV prevention drug hailed as breakthrough, but who gets access? — HIV prevention drug hailed as breakthrough, but who gets access? — Image credit: Al Jazeera English

Lenacapavir, a twice-a-year injection could transform HIV prevention, but it will not be available to all.

Flydubai stabbing: How safe are planes if a pilot turns violent?

1 Oct 2026, 15:15 UTC

Sunday in Japan: A Ugandan asylum seeker turns to filmmaking

1 Oct 2026, 15:15 UTC

Moroccan intelligence uses surveillance to ‘silence’ journalists: Amnesty

1 Oct 2026, 15:15 UTC

Western militaries are undermining Ukraine’s defence, experts say

1 Oct 2026, 15:15 UTC

The firemen who left the Poyo before the overflow to the judge of the dana: "We were surprised by the order of withdrawal"

1 Oct 2026, 14:43 UTC

New documents reveal that Cornell police omitted allegations of rape in the report to the Prosecutor's Office

1 Oct 2026, 14:42 UTC

HIV prevention drug hailed as breakthrough, but who gets access? | RocksNews